U.S. Markets open in 2 hrs 37 mins

Immunomedics, Inc. (IMMU)

NasdaqGM - NasdaqGM Delayed Price. Currency in USD
Add to watchlist
11.64+0.38 (+3.37%)
At close: 4:00PM EDT
People also watch
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue3,091.253,233.2475,653.091
Cost of Revenue482.6571,159.173264.915
Gross Profit2,608.5932,074.0745,388.176
Operating Expenses
Research Development51,776.39553,492.47141,735.888
Selling General and Administrative29,981.9317,589.6949,871.797
Non Recurring---
Total Operating Expenses---
Operating Income or Loss-79,149.733-59,008.091-46,219.509
Income from Continuing Operations
Total Other Income/Expenses Net-68,615.865298.363244.517
Earnings Before Interest and Taxes-147,765.598-58,709.728-45,974.992
Interest Expense5,479.8215,479.8212,090.75
Income Before Tax-153,245.419-64,189.549-48,065.742
Income Tax Expense20.867-5,053.83358.229
Minority Interest-771.081-710.74-611.974
Net Income From Continuing Ops-153,205.945-59,036.95-48,002.366
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-153,205.945-59,036.95-48,002.366
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-153,205.945-59,036.95-48,002.366